TY - JOUR
T1 - Triggered release of hydrophilic agents from plasmologen liposomes using visible light or acid
AU - Anderson, Valerie C.
AU - Thompson, David H.
N1 - Funding Information:
The authors gratefully acknowledge research support from the American Cancer Society, Oregon Division and the Whitaker Foundation.
PY - 1992/8/10
Y1 - 1992/8/10
N2 - Triggered release from liposomes composed of semi-synthetic 1-alk-1′-enyl-2-acyl-sn-glycero-3-phosphocholine (plasmologen) lipids has been demonstrated using either aerobic visible illumination or low pH to induce leakage. The photodynamic release system consists of three functional components: (1) small (< 1000 A ̊) unilamellar plasmologen vesicles (SUVs) containing encapsulated glucose, (2) oxygen and (3) zinc phthalocyanine (ZnPc) incorporated within the hydrophobic region of the SUV membrane. Irradiation (λ > 640 nm) at 37°C of air-saturated 1-alk-1′-enyl-2-palmitoyl-sn-glycero-3- phosphocholine (PlasPPC)/ 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (8:1 mol/mol) liposomes at physiologically relevant temperatures results in glucose release rates that are twice those of the corresponding dark control. Photolysis of argon-saturated PlasPPC/DPPC liposomes or of identical vesicles lacking either ZnPc or the plasmalogen vinyl ether bond exhibit glucose release curves which are indistinguishable from the dark control. Irradiation under identical conditions, but in the presence of 100 mM sodium azide, also results in no increased rate of glucose release above that of the dark control. TLC analysis indicates that oxidized lipid species are produced only in air-saturated, irradiated plasmologen liposomes. The acid lability of the plasmologen vinyl ether linkage has also been used to trigger release of entrapped calcein. At pH 4.2, the release rate at 37°C is increased 4-fold over rates observed at pH 8. TLC analysis indicates formation of a lysoplamalogen product. Taken together, these results indicate that both photodynamic and acid triggering can be used to increase plasmalogen liposome permeability and suggest that these liposomes are potentially useful for drug delivery applications.
AB - Triggered release from liposomes composed of semi-synthetic 1-alk-1′-enyl-2-acyl-sn-glycero-3-phosphocholine (plasmologen) lipids has been demonstrated using either aerobic visible illumination or low pH to induce leakage. The photodynamic release system consists of three functional components: (1) small (< 1000 A ̊) unilamellar plasmologen vesicles (SUVs) containing encapsulated glucose, (2) oxygen and (3) zinc phthalocyanine (ZnPc) incorporated within the hydrophobic region of the SUV membrane. Irradiation (λ > 640 nm) at 37°C of air-saturated 1-alk-1′-enyl-2-palmitoyl-sn-glycero-3- phosphocholine (PlasPPC)/ 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (8:1 mol/mol) liposomes at physiologically relevant temperatures results in glucose release rates that are twice those of the corresponding dark control. Photolysis of argon-saturated PlasPPC/DPPC liposomes or of identical vesicles lacking either ZnPc or the plasmalogen vinyl ether bond exhibit glucose release curves which are indistinguishable from the dark control. Irradiation under identical conditions, but in the presence of 100 mM sodium azide, also results in no increased rate of glucose release above that of the dark control. TLC analysis indicates that oxidized lipid species are produced only in air-saturated, irradiated plasmologen liposomes. The acid lability of the plasmologen vinyl ether linkage has also been used to trigger release of entrapped calcein. At pH 4.2, the release rate at 37°C is increased 4-fold over rates observed at pH 8. TLC analysis indicates formation of a lysoplamalogen product. Taken together, these results indicate that both photodynamic and acid triggering can be used to increase plasmalogen liposome permeability and suggest that these liposomes are potentially useful for drug delivery applications.
KW - Drug delivery
KW - Liposome
KW - Plasmalogen
KW - Triggered release
KW - Zine phthalocyanine
UR - http://www.scopus.com/inward/record.url?scp=0026808833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026808833&partnerID=8YFLogxK
U2 - 10.1016/0005-2736(92)90183-M
DO - 10.1016/0005-2736(92)90183-M
M3 - Article
C2 - 1504078
AN - SCOPUS:0026808833
SN - 0005-2736
VL - 1109
SP - 33
EP - 42
JO - Biochimica et Biophysica Acta - Biomembranes
JF - Biochimica et Biophysica Acta - Biomembranes
IS - 1
ER -